These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25605519)
1. C1 inhibitor deficiency: 2014 United Kingdom consensus document. Longhurst HJ; Tarzi MD; Ashworth F; Bethune C; Cale C; Dempster J; Gompels M; Jolles S; Seneviratne S; Symons C; Price A; Edgar D Clin Exp Immunol; 2015 Jun; 180(3):475-83. PubMed ID: 25605519 [TBL] [Abstract][Full Text] [Related]
2. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. Zuraw BL; Banerji A; Bernstein JA; Busse PJ; Christiansen SC; Davis-Lorton M; Frank MM; Li HH; Lumry WR; Riedl M; J Allergy Clin Immunol Pract; 2013; 1(5):458-67. PubMed ID: 24565617 [TBL] [Abstract][Full Text] [Related]
3. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Cicardi M; Bork K; Caballero T; Craig T; Li HH; Longhurst H; Reshef A; Zuraw B; Allergy; 2012 Feb; 67(2):147-57. PubMed ID: 22126399 [TBL] [Abstract][Full Text] [Related]
4. Prophylaxis in hereditary angioedema: a United Kingdom Delphi consensus. Yong PFK; Annals R; Diwakar L; Elkhalifa S; Gompels M; Jain R; Karim MY; Khan S; Metcalfe A; Noorani S; Steele C; Kiani-Alikhan S; Garcez T Clin Exp Immunol; 2024 Jun; 217(1):109-116. PubMed ID: 38456386 [TBL] [Abstract][Full Text] [Related]
5. Consensus on treatment goals in hereditary angioedema: A global Delphi initiative. Maurer M; Aygören-Pürsün E; Banerji A; Bernstein JA; Balle Boysen H; Busse PJ; Bygum A; Caballero T; Castaldo AJ; Christiansen SC; Craig T; Farkas H; Grumach AS; Hide M; Katelaris CH; Li HH; Longhurst H; Lumry WR; Magerl M; Martinez-Saguer I; Riedl MA; Zhi Y; Zuraw B J Allergy Clin Immunol; 2021 Dec; 148(6):1526-1532. PubMed ID: 34048855 [TBL] [Abstract][Full Text] [Related]
6. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. Bork K Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050 [TBL] [Abstract][Full Text] [Related]
8. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment. Zeerleder S; Levi M Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196 [TBL] [Abstract][Full Text] [Related]
9. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency. Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506 [TBL] [Abstract][Full Text] [Related]
10. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Riedl M Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830 [TBL] [Abstract][Full Text] [Related]
11. Optimizing hereditary angioedema management through tailored treatment approaches. Nasr IH; Manson AL; Al Wahshi HA; Longhurst HJ Expert Rev Clin Immunol; 2016; 12(1):19-31. PubMed ID: 26496459 [TBL] [Abstract][Full Text] [Related]
12. A UK national audit of hereditary and acquired angioedema. Jolles S; Williams P; Carne E; Mian H; Huissoon A; Wong G; Hackett S; Lortan J; Platts V; Longhurst H; Grigoriadou S; Dempster J; Deacock S; Khan S; Darroch J; Simon C; Thomas M; Pavaladurai V; Alachkar H; Herwadkar A; Abinun M; Arkwright P; Tarzi M; Helbert M; Bangs C; Pastacaldi C; Phillips C; Bennett H; El-Shanawany T Clin Exp Immunol; 2014 Jan; 175(1):59-67. PubMed ID: 23786259 [TBL] [Abstract][Full Text] [Related]
13. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Bowen T; Cicardi M; Bork K; Zuraw B; Frank M; Ritchie B; Farkas H; Varga L; Zingale LC; Binkley K; Wagner E; Adomaitis P; Brosz K; Burnham J; Warrington R; Kalicinsky C; Mace S; McCusker C; Schellenberg R; Celeste L; Hebert J; Valentine K; Poon MC; Serushago B; Neurath D; Yang W; Lacuesta G; Issekutz A; Hamed A; Kamra P; Dean J; Kanani A; Stark D; Rivard GE; Leith E; Tsai E; Waserman S; Keith PK; Page D; Marchesin S; Longhurst HJ; Kreuz W; Rusicke E; Martinez-Saguer I; Aygören-Pürsün E; Harmat G; Füst G; Li H; Bouillet L; Caballero T; Moldovan D; Späth PJ; Smith-Foltz S; Nagy I; Nielsen EW; Bucher C; Nordenfelt P; Xiang ZY Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S30-40. PubMed ID: 18220150 [TBL] [Abstract][Full Text] [Related]
14. Hereditary angioedema: current and emerging treatment options. Levy JH; Freiberger DJ; Roback J Anesth Analg; 2010 May; 110(5):1271-80. PubMed ID: 20418292 [TBL] [Abstract][Full Text] [Related]
15. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate. Tallroth GA Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289 [TBL] [Abstract][Full Text] [Related]
16. Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate. Shapiro RS; Zacek L J Infus Nurs; 2014; 37(4):284-90. PubMed ID: 24983261 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of hereditary angioedema. Canonica GW; Rossi O Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency. Bork K; Bernstein JA; Machnig T; Craig TJ J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). Sabharwal G; Craig T Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442 [TBL] [Abstract][Full Text] [Related]